MedTrace Logo

Safety Study to Assess the FEasibility of Use of the TRYTON Bifurcation Coronary Stent System (SAFE-TRY)

NCT01174433 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 241

Last updated 2012-07-04

No results posted yet for this study

Summary

To assess the safety and feasibility of the use of the Tryton bifurcation coronary stent system for the treatment of single de novo bifurcation lesions in native coronary arteries.

Conditions

Interventions

DEVICE

Tryton

Percutaneous coronary intervention of a bifurcation lesion, with a Tryton bifurcation coronary stent for the side branch and a drug-eluting coronary stent for the main branch

Sponsors & Collaborators

  • Mirano's Hospital, Mirano, Italy

    collaborator UNKNOWN

  • San Giacomo Apostolo Hospital, Castelfranco Veneto, Italy

    collaborator UNKNOWN

  • Conegliano Veneto's Hospital, Conegliano Veneto, Italy

    collaborator UNKNOWN

  • University of Padova

    lead OTHER

Principal Investigators

  • Giuseppe Tarantini, MD, Ph.D. · University of Padua, Department of Cardiac, Thoracic and Vascular Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01174433 on ClinicalTrials.gov